Bribery claims irrelevant in terrorism lawsuit, say life sciences companies

Five pharmaceutical and healthcare companies have hit back against a lawsuit claiming they bribed Iraqi officials and inadvertently funded terrorist attacks.

Get unlimited access to all Global Investigations Review content